TY - JOUR
T1 - Availability of assisted peritoneal dialysis in Europe
T2 - call for increased and equal access
AU - Brown, Edwina A
AU - Ekstrand, Agneta
AU - Gallieni, Maurizio
AU - Gorrín, Maite Rivera
AU - Gudmundsdottir, Helga
AU - Guedes, Anabela Malho
AU - Heidempergher, Marco
AU - Kitsche, Benno
AU - Lobbedez, Thierry
AU - Lundström, Ulrika Hahn
AU - McCarthy, Kate
AU - Mellotte, George J
AU - Moranne, Olivier
AU - Petras, Dimitrios
AU - Povlsen, Johan V
AU - Punzalan, Sally
AU - Wiesholzer, Martin
N1 - Funding Information:
Baxter Healthcare (Europe) funded and arranged the virtual meetings of the authors. E.A.B. is supported by the Imperial National Institute for Health Research Biomedical Research Centre. M.W. is supported by the Karl Landsteiner Society, Institute for Nephrology.
Publisher Copyright:
© 2022 The Author(s).
PY - 2022/11/1
Y1 - 2022/11/1
N2 - INTRODUCTION: Availability of assisted PD (asPD) increases access to dialysis at home, particularly for the increasing numbers of older and frail people with advanced kidney disease. Although asPD has been widely used in some European countries for many years, it remains unavailable or poorly utilised in others. A group of leading European nephrologists have therefore formed a group to drive increased availability of asPD in Europe and in their own countries.METHODS: Members of the group filled in a proforma with the following headings: personal experience, country experience, who are the assistants, funding of asPD, barriers to growth, what is needed to grow, and their top 3 priorities.RESULTS: Only 5 of the 13 countries surveyed provided publicly funded reimbursement for asPD. The use of asPD depends on overall attitudes to PD with all respondents mentioning need for nephrology team education and/or patient education and involvement in dialysis modality decision making.CONCLUSION AND CALL TO ACTION: Many people with advanced kidney disease would prefer to have their dialysis at home, yet if the frail patient chooses PD most healthcare systems cannot provide their choice. AsPD should be available in all countries in Europe and for all renal centres. The top priorities to make this happen are education of renal healthcare teams about the advantages of PD, education of and discussion with patients and their families as they approach the need for dialysis, and engagement with policy makers and healthcare providers to develop and support assistance for PD.
AB - INTRODUCTION: Availability of assisted PD (asPD) increases access to dialysis at home, particularly for the increasing numbers of older and frail people with advanced kidney disease. Although asPD has been widely used in some European countries for many years, it remains unavailable or poorly utilised in others. A group of leading European nephrologists have therefore formed a group to drive increased availability of asPD in Europe and in their own countries.METHODS: Members of the group filled in a proforma with the following headings: personal experience, country experience, who are the assistants, funding of asPD, barriers to growth, what is needed to grow, and their top 3 priorities.RESULTS: Only 5 of the 13 countries surveyed provided publicly funded reimbursement for asPD. The use of asPD depends on overall attitudes to PD with all respondents mentioning need for nephrology team education and/or patient education and involvement in dialysis modality decision making.CONCLUSION AND CALL TO ACTION: Many people with advanced kidney disease would prefer to have their dialysis at home, yet if the frail patient chooses PD most healthcare systems cannot provide their choice. AsPD should be available in all countries in Europe and for all renal centres. The top priorities to make this happen are education of renal healthcare teams about the advantages of PD, education of and discussion with patients and their families as they approach the need for dialysis, and engagement with policy makers and healthcare providers to develop and support assistance for PD.
KW - Europe
KW - Humans
KW - Kidney Diseases
KW - Kidney Failure, Chronic/therapy
KW - Peritoneal Dialysis
KW - Renal Dialysis
KW - frailty
KW - community care
KW - peritoneal dialysis
KW - quality of life
KW - equity
UR - http://www.scopus.com/inward/record.url?scp=85135443860&partnerID=8YFLogxK
U2 - 10.1093/ndt/gfac193
DO - 10.1093/ndt/gfac193
M3 - Journal article
C2 - 35671088
SN - 0931-0509
VL - 37
SP - 2080
EP - 2089
JO - Nephrology Dialysis Transplantation
JF - Nephrology Dialysis Transplantation
IS - 11
ER -